Leverage Shares 2X Long RTX Daily ETF
RTXG
3 hedge funds and large institutions have $276K invested in Leverage Shares 2X Long RTX Daily ETF in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
245% more capital invested
Capital invested by funds: $80.1K → $276K (+$196K)
14.4% more ownership
Funds ownership: 7.69% → 22.09% (+14%)
0% more funds holding
Funds holding: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Optiver Holding
Amsterdam,
Netherlands
|
+$182K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$154 |
| 3 |
Citigroup
New York
|
+$22 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$21 |
RTXG Hedge Fund Activity: Q4 2025 in Review
3 of the 8,226 institutional investors tracked by Wall St. Rank reported a position in Leverage Shares 2X Long RTX Daily ETF (RTXG) for Q4 2025, worth a combined $276K — up 245% from $80.1K a quarter earlier.
Fund positioning in RTXG was balanced in Q4 2025: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Optiver Holding, adding an estimated $182K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $21 sold.
- 3 institutional investors held Leverage Shares 2X Long RTX Daily ETF (RTXG) as of Q4 2025, unchanged from Q3 2025.
- Funds reported $276K of Leverage Shares 2X Long RTX Daily ETF stock for Q4 2025, up 245% quarter-over-quarter.
- 1 fund opened new Leverage Shares 2X Long RTX Daily ETF positions in Q4 2025 and 1 closed out, a net change of 0 holders.
- The largest Leverage Shares 2X Long RTX Daily ETF buyer in Q4 2025 was Optiver Holding, an estimated $182K added.
- The largest Leverage Shares 2X Long RTX Daily ETF seller in Q4 2025 was Tower Research Capital (TRC), an estimated $21 sold.
Based on aggregated 13F filings for Q4 2025.